A Single 60.000 IU Dose of Erythropoietin Does Not Improve Short-Term Aerobic Exercise Performance in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

A Single 60.000 IU Dose of Erythropoietin Does Not Improve Short-Term Aerobic Exercise Performance in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Crossover Trial

Erythropoietin (EPO) boosts exercise performance through increase in oxygen transport capacity following regular administration of EPO but preclinical study results suggest that single high dose of EPO also may improve exercise capacity. Twenty-nine healthy subjects (14 males/15 females; age: 25 ± 3...

Full description

Bibliographic Details
Main Authors: Thomas Haider, Victor Diaz, Jamie Albert, Maria Alvarez-Sanchez, Markus Thiersch, Marco Maggiorini, Matthias P. Hilty, Christina M. Spengler, Max Gassmann
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Physiology
Subjects:
EPO
high dose
oxygen transport
erythropoiesis
doping
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2020.537389/full

Internet

https://www.frontiersin.org/article/10.3389/fphys.2020.537389/full

Similar Items